- Current report filing (8-K)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

---

FORM 8-K

---

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) February 28, 2011  

---

Aastrom Biosciences, Inc.
(Exact name of registrant as specified in its charter)

Michigan		0-22025		943096597
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

	24 Frank Lloyd Wright Drive P.O. Box 376 Ann Arbor, Michigan		48106
	(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code:   [phone]

________________________________________________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
	[    ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	[    ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	[    ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	[    ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

Item 2.02. Results of Operations and Financial Condition.

On February 28, 2011 the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

    Exhibit 99.1.       Press release dated February 28, 2011

---

SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		Aastrom Biosciences, Inc. (Registrant)
February 28, 2011 (Date)		/s/   TIMOTHY M. MAYLEBEN Timothy M. Mayleben Chief Executive Officer and President

---

	Exhibit Index
	99.1	Press release dated February 28, 2011